Coherus Biosciences | CHRS - Ebitda



金融业
股票价格
USD
资产
USD 191.18M
现金及等价物
USD 82.92M
销售成本
USD 4.05M
流动资产
USD 133.79M
流动负债
USD 75.51M
债务
USD 294.93M
股息收益率
0
EBIT
USD -39.08M
EBITDA
USD -43.33M
员工
306
EPS每股收益
USD -0.43
股本和储备
USD 60.84M
销售毛利
USD 8.7M
债务利息支出
USD 2.25M
贷款资金
USD 51.08M
市值
USD 130.2M
净收入
USD -37.64M
营业费用
USD 51.83M
营业利润
USD -39.08M
普通股股本
USD 121.16M
税前利润
USD -46.35M
销售收入
USD 12.75M
销售和管理费用
USD 15M
股票
USD 5.67M
贸易债权人
USD 13.17M
应收帐款人
USD 18.42M


Ebitda 更改 日
AbbVie USD 3.69B 1.68B 2026-03
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 139.22M 58.96M 2026-06
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 3.86B 1.28B 2026-03
Baxter International USD 309M 756M 2026-03
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 10.29B 1.86B 2026-03
Fujifilm JPY 101.61B 48.31B 2026-06
Gilead Sciences USD 3.51B 489M 2026-03
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Merck USD -1.54B 7.84B 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06
Xencor USD -34.63M 86.74M 2026-06
Zoetis USD 939M 0 2026-03